Literature DB >> 1877368

Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism.

M Ballarín1, B B Fredholm, S Ambrosio, N Mahy.   

Abstract

The level of purines in the striatum of awake, freely moving rats was studied using microdialysis. The calculated extracellular concentration of adenosine and its metabolites inosine and hypoxanthine was very high immediately after implantation of the dialysis probe but decreased within 24 h to a level which remained stable for two days. Using in vitro calibration to determine the relative recovery of the dialysis probes we estimated resting levels in the striatal extracellular space to be 40, 110 and 580 nM, respectively. Inhibition of adenosine deaminase by deoxycoformycin produced a significant 1.4-fold increase in extracellular adenosine levels and a fall in inosine and hypoxanthine. A combination of three uptake blockers (dipyridamole, lidoflazine and nitrobenzylthioinosine), caused a 4.5-fold increase in extracellular adenosine levels without any change in inosine or hypoxanthine levels. After uptake inhibition deoxycoformycin did not have any significant effect. The present results show that the microdialysis technique can be used to determine levels of purines in the extracellular fluid of defined brain regions in awake animals. The high levels recorded during the first several hours after implantation may be artefactually high and reflect trauma. The results also show that adenosine levels can be altered in vivo by inhibitors of adenosine transport and adenosine deaminase. The present results indicate that the physiological adenosine level in striatal extracellular space is in the range 40-460 nM.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1877368     DOI: 10.1111/j.1748-1716.1991.tb09133.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  57 in total

1.  Phasic and tonic attenuation of EPSPs by inward rectifier K+ channels in rat hippocampal pyramidal cells.

Authors:  Tomoko Takigawa; Christian Alzheimer
Journal:  J Physiol       Date:  2002-02-15       Impact factor: 5.182

2.  Effects of an inhibitor of adenosine deaminase, deoxycoformycin, and of nucleoside transport, propentofylline, on post-ischemic recovery of adenine nucleotides in rat brain.

Authors:  J W Phillis; M H O'Regan
Journal:  Neurochem Res       Date:  1996-03       Impact factor: 3.996

Review 3.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

Review 4.  Neuroadaptations in adenosine receptor signaling following long-term ethanol exposure and withdrawal.

Authors:  Tracy R Butler; Mark A Prendergast
Journal:  Alcohol Clin Exp Res       Date:  2011-07-18       Impact factor: 3.455

5.  Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers.

Authors:  Zhan-Guo Gao; Dennis Verzijl; Annelien Zweemer; Kai Ye; Anikó Göblyös; Adriaan P Ijzerman; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2011-06-21       Impact factor: 5.858

6.  Real-time monitoring of extracellular adenosine using enzyme-linked microelectrode arrays.

Authors:  Jason M Hinzman; Justin L Gibson; Ryan D Tackla; Mark S Costello; Jason J Burmeister; Jorge E Quintero; Greg A Gerhardt; Jed A Hartings
Journal:  Biosens Bioelectron       Date:  2015-07-07       Impact factor: 10.618

7.  Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations.

Authors:  Mingyan Zhou; Haichuan Duan; Karen Engel; Li Xia; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2010-06-30       Impact factor: 3.922

Review 8.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

9.  Release of endogenous adenosine and its metabolites by the activation of NMDA receptors in the rat hippocampus in vivo.

Authors:  Y Chen; D I Graham; T W Stone
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

10.  Adenosine neuromodulation and traumatic brain injury.

Authors:  T A Lusardi
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.